Medulloblastoma in infants: The critical issues of the dilemma

Current Oncology

Volumn 17, Issue 3, 2010, Pages 2-3

  Bouffet, E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chemotherapy; Clinical trials; Infants; Medulloblastoma; Radiation

Indexed keywords

AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN DEVELOPMENT; BRAIN METASTASIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; COGNITIVE DEFECT; CONSENSUS DEVELOPMENT; EDITORIAL; HUMAN; INFANT; INFANT DISEASE; INTERNATIONAL COOPERATION; MEDULLOBLASTOMA; POSTOPERATIVE CARE; RADIATION DOSE; SIGNAL TRANSDUCTION; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77953102123     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i3.504     Document Type: Editorial

References (11)

1. Lafay-Cousin L, Bouffet E, Hawkins C, Amid A, Huang A, Mabbott DJ. Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma. Curr Oncol 2009;16(6):21-8.
2. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-31.
3. Duffner PK, Krischer JP, Horowitz ME, et al. Second malig-nancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol 1998;44:313-16.
4. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-86.
5. Grill J, Sainte-Rose C, Jouvet A, et al. Treatment of medulloblas-toma with postoperative chemotherapy alone: an sfop prospec-tive trial in young children. Lancet Oncol 2005;6:573-80.
6. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemo-therapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 2005;23:7621-31.
7. Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose metho-trexate for young children with newly diagnosed high-risk dis-seminated medulloblastoma. J Clin Oncol 2004;22:4881-7.
8. Johnston DL, Keene D, Bartels U, et al. Medulloblastoma in children under the age of three years: a retrospective Canadian review. J Neurooncol 2009;94:51-6.
9. Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diag-nosed malignant brain tumors. J Clin Oncol 1998;16:210-21.
10. Dhall G, Grodman H, Ji L, et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblas-toma treated with chemotherapy on the "Head Start" i and ii protocols. Pediatr Blood Cancer 2008;50:1169-75.
11. Gajjar A, Hernan R, Kocak M, et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratifica-tion system for medulloblastoma. J Clin Oncol 2004;22:984-93.